Scenic Biotech B.V., founded in 2017 and based in Amsterdam, specializes in developing genomics and immunotherapy technologies aimed at addressing cancer and rare genetic diseases at their genetic roots. The company focuses on identifying disease-suppressing genes that serve as "off-switches" for GPCR signaling, enabling innovative therapeutic interventions. Scenic Biotech's approach involves unlocking genetic modifiers that can suppress or block the effects of disease-causing mutated genes. This technology allows for the rapid identification and validation of novel drug targets, facilitating the development of disease-modifying therapeutics that aim to improve the lives of patients suffering from severe conditions.
Silverflow B.V. is a cloud-based processing platform based in Amsterdam, Netherlands, specializing in payment gateway solutions for businesses. Founded in 2019, the company enables payment service providers (PSPs), acquirers, and merchants to directly access card networks, facilitating technological advancements in payment processing. Silverflow offers card-acquiring processing as a service, providing real-time insights into transaction fees and access to smart data directly from the networks. This streamlined approach enhances agility, transparency, and security in global payment operations, allowing payment providers to better serve their clients.
Castor is an international health-tech company that offers a cloud-based clinical data platform designed to streamline the clinical trial process for researchers around the world. Founded by CEO Derk Arts, MD, Ph.D., the platform is utilized by over 50,000 researchers in 90 countries and has facilitated more than 4,000 studies across diverse therapeutic areas such as diabetes, cardiovascular diseases, rare diseases, infectious diseases, and oncology. Researchers using Castor generate substantial amounts of data from both traditional and remote trials, having reached significant milestones of 180 million data points and 2 million enrolled patients. The company's mission is to enhance the reusability of research data, supporting AI-driven clinical trials and ultimately maximizing the impact of data to improve medical research globally.
Sentinels is an AI-powered transaction monitoring startup. Sentinels provide fintech companies with a cloud-based intelligent transaction monitoring solution dedicated to data-driven compliance for the financial industry and help them crackdown on money laundering and other illegal activity passing.
EclecticIQ B.V. is a global provider of threat intelligence, hunting, and response technology, supporting government organizations and commercial enterprises in enhancing their cybersecurity posture. Founded in 2014 and headquartered in Amsterdam, with additional offices in Herndon, Virginia; London, United Kingdom; and Chi?inau, Moldova, the company offers a range of products and services. These include the EclecticIQ Platform, a comprehensive threat intelligence platform; the EclecticIQ Fusion Center, which delivers multi-source threat intelligence bundles; and the EclecticIQ Academy for cyber threat intelligence training. The company also provides consulting services, team collaboration tools, and various integrations to optimize incident response and security controls. With a focus on building defenses against emerging threats, EclecticIQ has expanded its capabilities through acquisitions, such as Polylogyx's endpoint technology, to further enhance its offerings for clients facing sophisticated cyber threats.
Silverflow B.V. is a cloud-based processing platform based in Amsterdam, Netherlands, specializing in payment gateway solutions for businesses. Founded in 2019, the company enables payment service providers (PSPs), acquirers, and merchants to directly access card networks, facilitating technological advancements in payment processing. Silverflow offers card-acquiring processing as a service, providing real-time insights into transaction fees and access to smart data directly from the networks. This streamlined approach enhances agility, transparency, and security in global payment operations, allowing payment providers to better serve their clients.
EclecticIQ B.V. is a global provider of threat intelligence, hunting, and response technology, supporting government organizations and commercial enterprises in enhancing their cybersecurity posture. Founded in 2014 and headquartered in Amsterdam, with additional offices in Herndon, Virginia; London, United Kingdom; and Chi?inau, Moldova, the company offers a range of products and services. These include the EclecticIQ Platform, a comprehensive threat intelligence platform; the EclecticIQ Fusion Center, which delivers multi-source threat intelligence bundles; and the EclecticIQ Academy for cyber threat intelligence training. The company also provides consulting services, team collaboration tools, and various integrations to optimize incident response and security controls. With a focus on building defenses against emerging threats, EclecticIQ has expanded its capabilities through acquisitions, such as Polylogyx's endpoint technology, to further enhance its offerings for clients facing sophisticated cyber threats.
Castor is an international health-tech company that offers a cloud-based clinical data platform designed to streamline the clinical trial process for researchers around the world. Founded by CEO Derk Arts, MD, Ph.D., the platform is utilized by over 50,000 researchers in 90 countries and has facilitated more than 4,000 studies across diverse therapeutic areas such as diabetes, cardiovascular diseases, rare diseases, infectious diseases, and oncology. Researchers using Castor generate substantial amounts of data from both traditional and remote trials, having reached significant milestones of 180 million data points and 2 million enrolled patients. The company's mission is to enhance the reusability of research data, supporting AI-driven clinical trials and ultimately maximizing the impact of data to improve medical research globally.
Cashforce BV operates a smart cash flow management and forecasting platform designed to help organizations optimize their financial operations. Founded in 2013 and headquartered in Antwerp, Belgium, with additional offices in New York, Amsterdam, Copenhagen, and London, the company serves sectors such as wholesale and distribution, transportation, logistics, and manufacturing. The platform allows users to forecast cash flows across multiple companies, bank accounts, and currencies, enabling them to identify potential cash shortages or surpluses in advance. Cashforce's unique offerings include seamless integration with various ERP and banking systems, detailed transaction-level visibility, and an AI-based simulation engine that supports multiple cash flow scenarios and impact analyses. The company has a strategic alliance with Treasury Intelligence Solutions GmbH and provides cash visibility to multinational corporations in over 120 countries.
EclecticIQ B.V. is a global provider of threat intelligence, hunting, and response technology, supporting government organizations and commercial enterprises in enhancing their cybersecurity posture. Founded in 2014 and headquartered in Amsterdam, with additional offices in Herndon, Virginia; London, United Kingdom; and Chi?inau, Moldova, the company offers a range of products and services. These include the EclecticIQ Platform, a comprehensive threat intelligence platform; the EclecticIQ Fusion Center, which delivers multi-source threat intelligence bundles; and the EclecticIQ Academy for cyber threat intelligence training. The company also provides consulting services, team collaboration tools, and various integrations to optimize incident response and security controls. With a focus on building defenses against emerging threats, EclecticIQ has expanded its capabilities through acquisitions, such as Polylogyx's endpoint technology, to further enhance its offerings for clients facing sophisticated cyber threats.
Aidence B.V. develops and delivers a software platform for radiologists that automatically detects, classifies, and tracks the disorder on multiple imaging modalities. The company provides artificial intelligence solution that enables computer to read medical images and automatically provide structured reports. Aidence B.V. was founded in 2015 and is based in Amsterdam, the Netherlands.
Polarsteps is a travel tracking platform that allows users to plan, track, and share their journeys effortlessly. The app automatically records travel routes and key locations in real time, creating a detailed account of each trip. Once connected to the internet, it uploads the captured information, including photos, to a personalized page, visually represented on a colorful world map. This feature enables travelers to create and maintain a digital album of their experiences, which can be easily shared with friends and family. By turning travel moments into lasting memories, Polarsteps enhances the overall travel experience for users.
Castor is an international health-tech company that offers a cloud-based clinical data platform designed to streamline the clinical trial process for researchers around the world. Founded by CEO Derk Arts, MD, Ph.D., the platform is utilized by over 50,000 researchers in 90 countries and has facilitated more than 4,000 studies across diverse therapeutic areas such as diabetes, cardiovascular diseases, rare diseases, infectious diseases, and oncology. Researchers using Castor generate substantial amounts of data from both traditional and remote trials, having reached significant milestones of 180 million data points and 2 million enrolled patients. The company's mission is to enhance the reusability of research data, supporting AI-driven clinical trials and ultimately maximizing the impact of data to improve medical research globally.
Scenic Biotech B.V., founded in 2017 and based in Amsterdam, specializes in developing genomics and immunotherapy technologies aimed at addressing cancer and rare genetic diseases at their genetic roots. The company focuses on identifying disease-suppressing genes that serve as "off-switches" for GPCR signaling, enabling innovative therapeutic interventions. Scenic Biotech's approach involves unlocking genetic modifiers that can suppress or block the effects of disease-causing mutated genes. This technology allows for the rapid identification and validation of novel drug targets, facilitating the development of disease-modifying therapeutics that aim to improve the lives of patients suffering from severe conditions.
Bloomon B.V. is an online retailer based in Amsterdam, Netherlands, specializing in the delivery of quality flowers across Europe. Founded in 2014, the company provides a platform that connects consumers directly with flower growers. Bloomon operates on a subscription model, allowing customers to easily arrange their orders online, and offering the flexibility to pause, change, or cancel deliveries without commitment. This model enhances the customer experience by allowing users to customize their flower arrangements and packaging. Bloomon prioritizes client satisfaction and product quality, focusing on providing unique floral experiences rather than competing with other businesses in the market.
EclecticIQ B.V. is a global provider of threat intelligence, hunting, and response technology, supporting government organizations and commercial enterprises in enhancing their cybersecurity posture. Founded in 2014 and headquartered in Amsterdam, with additional offices in Herndon, Virginia; London, United Kingdom; and Chi?inau, Moldova, the company offers a range of products and services. These include the EclecticIQ Platform, a comprehensive threat intelligence platform; the EclecticIQ Fusion Center, which delivers multi-source threat intelligence bundles; and the EclecticIQ Academy for cyber threat intelligence training. The company also provides consulting services, team collaboration tools, and various integrations to optimize incident response and security controls. With a focus on building defenses against emerging threats, EclecticIQ has expanded its capabilities through acquisitions, such as Polylogyx's endpoint technology, to further enhance its offerings for clients facing sophisticated cyber threats.
Wercker B.V. is a cloud-based platform that specializes in automating the development, testing, and deployment of applications and microservices. Founded in 2012 and headquartered in Amsterdam, with additional offices in London and San Francisco, Wercker provides developers with tools to streamline their workflow through features such as a local command-line interface and API. The platform supports a continuous integration and continuous delivery (CI/CD) model, allowing users to build, test, and deploy without leaving their local development environment. It also incorporates social features, enabling team collaboration by showcasing project activities and facilitating project invitations. By integrating with popular developer platforms, Wercker aims to enhance the efficiency of modern cloud application development.
Audion Therapeutics BV is a biopharmaceutical company based in Amsterdam, the Netherlands, that specializes in the discovery, development, and commercialization of therapeutic drugs and delivery technologies for ear-related diseases, particularly hearing loss. Founded in 2008, the company is focused on a small molecule drug discovery program aimed at regenerating inner hair cells, which are crucial for hearing. Audion Therapeutics holds a comprehensive intellectual property portfolio that includes innovative molecules, advanced delivery systems, and drug discovery tools specifically designed for hearing and hearing loss research.
Bloomon B.V. is an online retailer based in Amsterdam, Netherlands, specializing in the delivery of quality flowers across Europe. Founded in 2014, the company provides a platform that connects consumers directly with flower growers. Bloomon operates on a subscription model, allowing customers to easily arrange their orders online, and offering the flexibility to pause, change, or cancel deliveries without commitment. This model enhances the customer experience by allowing users to customize their flower arrangements and packaging. Bloomon prioritizes client satisfaction and product quality, focusing on providing unique floral experiences rather than competing with other businesses in the market.
Aito BV specializes in developing and manufacturing advanced touch solutions for physical user interfaces, including buttons, touch pads, and screens. Founded in 2005 and headquartered in Zaanstad, the Netherlands, the company offers a variety of products such as touch demos that detect human touch through different overlay materials, switching units with integrated electronic designs, and touch control devices for various applications. Aito's innovative technology enhances user experiences across a range of products, including smartphones, laptops, and car infotainment systems. The company operates engineering, research, and prototyping facilities in the Netherlands and Finland, while licensed manufacturing occurs in Singapore and China. Aito is a subsidiary of d-Switch BV and is recognized as a leader in the global human interface market.
Aito BV specializes in developing and manufacturing advanced touch solutions for physical user interfaces, including buttons, touch pads, and screens. Founded in 2005 and headquartered in Zaanstad, the Netherlands, the company offers a variety of products such as touch demos that detect human touch through different overlay materials, switching units with integrated electronic designs, and touch control devices for various applications. Aito's innovative technology enhances user experiences across a range of products, including smartphones, laptops, and car infotainment systems. The company operates engineering, research, and prototyping facilities in the Netherlands and Finland, while licensed manufacturing occurs in Singapore and China. Aito is a subsidiary of d-Switch BV and is recognized as a leader in the global human interface market.